Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Nov, 2017 | Pages:
98 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
This report studies the global Autologous Matrix-Induced Chondrogenesis (AMIC) market, analyzes and researches the Autologous Matrix-Induced Chondrogenesis (AMIC) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Anika Therapeutics, Inc.
Arthro-Kinetics
B. Braun Melsungen AG
BioTissue AG
CartiHeal
Geistlich Pharma AG
JRI Orthopaedics Ltd.
Matricel GmbH
Smith & Nephew plc
Zimmer Biomet Holdings
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, the product can be split into
Hyaluronic Acid
Collagen
Polyethylene glycol (PEG)
polylactic-co-glycolic acid (PGLA)
Others
Market segment by Application, Autologous Matrix-Induced Chondrogenesis (AMIC) can be split into
Knee Cartilage Repair
Hip Cartilage Repair
Elbow Cartilage Repair
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, Status and Forecast 2022
1 Industry Overview of Autologous Matrix-Induced Chondrogenesis (AMIC)
1.1 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Overview
1.1.1 Autologous Matrix-Induced Chondrogenesis (AMIC) Product Scope
1.1.2 Market Status and Outlook
1.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Type
1.3.1 Hyaluronic Acid
1.3.2 Collagen
1.3.3 Polyethylene glycol (PEG)
1.3.4 polylactic-co-glycolic acid (PGLA)
1.3.5 Others
1.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Market by End Users/Application
1.4.1 Knee Cartilage Repair
1.4.2 Hip Cartilage Repair
1.4.3 Elbow Cartilage Repair
1.4.4 Others
2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Competition Analysis by Players
2.1 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Anika Therapeutics, Inc.
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Arthro-Kinetics
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 B. Braun Melsungen AG
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 BioTissue AG
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 CartiHeal
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Geistlich Pharma AG
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 JRI Orthopaedics Ltd.
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Matricel GmbH
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Smith & Nephew plc
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Zimmer Biomet Holdings
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Value) (2012-2017)
3.10.5 Recent Developments
4 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type and Application (2012-2017)
4.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Type (2012-2017)
4.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2012-2017)
4.3 Potential Application of Autologous Matrix-Induced Chondrogenesis (AMIC) in Future
4.4 Top Consumer/End Users of Autologous Matrix-Induced Chondrogenesis (AMIC)
5 United States Autologous Matrix-Induced Chondrogenesis (AMIC) Development Status and Outlook
5.1 United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2012-2017)
5.2 United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Market Share by Players (2016 and 2017)
6 EU Autologous Matrix-Induced Chondrogenesis (AMIC) Development Status and Outlook
6.1 EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2012-2017)
6.2 EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Market Share by Players (2016 and 2017)
7 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Development Status and Outlook
7.1 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2012-2017)
7.2 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Market Share by Players (2016 and 2017)
8 China Autologous Matrix-Induced Chondrogenesis (AMIC) Development Status and Outlook
8.1 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2012-2017)
8.2 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Market Share by Players (2016 and 2017)
9 India Autologous Matrix-Induced Chondrogenesis (AMIC) Development Status and Outlook
9.1 India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2012-2017)
9.2 India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Development Status and Outlook
10.1 Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (2012-2017)
10.2 Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Value) by Regions (2017-2022)
11.1.1 United States Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2017-2022)
11.1.2 EU Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2017-2022)
11.1.3 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2017-2022)
11.1.4 China Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2017-2022)
11.1.5 India Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue and Growth Rate (2017-2022)
11.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Value) by Type (2017-2022)
11.3 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size by Application (2017-2022)
12 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Dynamics
12.1 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Opportunities
12.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Product Scope
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) (2012-2017)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Regions in 2016
Figure United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Type in 2016
Figure Hyaluronic Acid Market Size (Million USD) and Growth Rate (2012-2017)
Figure Collagen Market Size (Million USD) and Growth Rate (2012-2017)
Figure Polyethylene glycol (PEG) Market Size (Million USD) and Growth Rate (2012-2017)
Figure polylactic-co-glycolic acid (PGLA) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Others Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Share by Application in 2016
Table Key Downstream Customer in Knee Cartilage Repair
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate in Knee Cartilage Repair (2012-2017)
Table Key Downstream Customer in Hip Cartilage Repair
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate in Hip Cartilage Repair (2012-2017)
Table Key Downstream Customer in Elbow Cartilage Repair
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate in Elbow Cartilage Repair (2012-2017)
Table Key Downstream Customer in Others
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2016 and 2017)
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Table Anika Therapeutics, Inc. Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of Anika Therapeutics, Inc. (2012-2017)
Figure Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table Arthro-Kinetics Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of Arthro-Kinetics (2012-2017)
Figure Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table B. Braun Melsungen AG Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of B. Braun Melsungen AG (2012-2017)
Figure B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table BioTissue AG Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of BioTissue AG (2012-2017)
Figure BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table CartiHeal Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of CartiHeal (2012-2017)
Figure CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table Geistlich Pharma AG Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of Geistlich Pharma AG (2012-2017)
Figure Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table JRI Orthopaedics Ltd. Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of JRI Orthopaedics Ltd. (2012-2017)
Figure JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table Matricel GmbH Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of Matricel GmbH (2012-2017)
Figure Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table Smith & Nephew plc Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of Smith & Nephew plc (2012-2017)
Figure Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table Zimmer Biomet Holdings Basic Information List
Table Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue (Million USD) of Zimmer Biomet Holdings (2012-2017)
Figure Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Business Revenue Market Share in 2016
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Type (2012-2017)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2012
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2013
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2014
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2015
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2016
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2017
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application (2012-2017)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2012
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2013
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2014
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2015
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2016
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Autologous Matrix-Induced Chondrogenesis (AMIC)
Figure United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2012-2017)
Figure United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure United States Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Figure EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2012-2017)
Figure EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure EU Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Figure Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2012-2017)
Figure Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2012-2017)
Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Figure India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2012-2017)
Figure India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Figure Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2016
Figure Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Players in 2017
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Regions (2017-2022)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Regions (2017-2022)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Regions in 2017
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Regions in 2022
Figure United States Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Type (2017-2022)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2017
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Share by Type in 2022
Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application (2017-2022)
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2017
Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size (Million USD) by Application in 2022
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
